AzTrials
AzTrials

Attachment DisorderNCT07922382

Integrated Attachment Theory

A study testing IAT in people with Attachment Disorder, run by Boston University Charles River Campus at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot randomized waitlist-controlled study will evaluate the feasibility and preliminary effects of a 12-week Integrated Attachment Theory (IAT) psychoeducational coaching program in adults ages 18-65 with an insecure attachment pattern identified through study screening. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Attachment Disorder
What is being tested?
IAT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
Dec 2026to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Speak and read English sufficiently to complete study questionnaires and the IAT program
  • Meets the PDS attachment-style eligibility criterion for insecure attachment
  • Able and willing to attend required in-person Boston University (BU) research visits
  • Able and willing, if assigned, to participate in the 12-week remote IAT program.

Who cannot join

  • Self-reported neurological disorder or condition
  • Self-reported psychiatric/mental-health disorder
  • Patient Health Questionnaire-9 (PHQ-9) total score >14
  • Generalized Anxiety Disorder-7 (GAD-7) total score >14
  • Failure to meet the PDS attachment-style eligibility criterion
  • Inability to complete required study procedures
  • A safety concern that makes participation inappropriate.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Meryem Yücel, PhD contact

617-353-1181

mayucel@bu.edu

United States1 site
  • Boston University Center for Life Science & Engineering

    Boston, Massachusetts, 02215

    Meryem Yücel, PhD, 617-353-1181, mayucel@bu.edu

    Miray Altinkaynak, PhD MPH

Other trials in United States

About this study

This pilot randomized waitlist-controlled study will evaluate the feasibility and preliminary effects of a 12-week Integrated Attachment Theory (IAT) psychoeducational coaching program in adults ages 18-65 with an insecure attachment pattern identified through study screening.

Eligible participants will be randomized 1:1 to immediate IAT or a 12-week waitlist followed by IAT. The immediate group will complete in-person Boston University assessments before and after IAT; the waitlist group will complete assessments at baseline, after the 12-week waiting period, and after subsequently completing IAT.

The primary objectives are to determine whether the study procedures and intervention are feasible and to estimate the magnitude and variability of pre/post changes. The investigators hypothesize that IAT will be associated with improvement in attachment-related patterns, emotion regulation, interpersonal functioning, and well-being, together with changes in physiological and cortical responses during attachment-related emotion regulation compared with the waitlist period.

Being tested
IAT
Keywords
Integrated Attachment Theory (IAT), Personal Development School, Interpersonal functioning, functional near-infrared spectroscopy (fNIRS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IATBehavioural

    IAT provides12 consecutive weekly remote Zoom sessions delivered by Personal Development School (PDS). Each session lasts approximately 2.5 hours with about 90 minutes of teaching plus 1 hour of supervised support. Participants will work in small breakout rooms with two participants per room during the support portion. The 12-week curriculum addresses core beliefs, relationship needs, emotional/nervous-system patterns, communication, boundaries, and behaviors. Participants will also complete approximately 10 minutes of daily skills practice/homework.

Study groups in NCT07922382
Study groupRoleWhat they receive
Immediate Integrated Attachment Theory (IAT)ExperimentalParticipants randomized to this arm will immediately receive the 12 week IAT intervention.
Receives: Behavioral: IAT
Waitlist followed by IATActive comparatorParticipants randomized to this arm will be put on a 12 week waitlist and after will receive the IAT intervention.
Receives: Behavioral: IAT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of IAT intervention

    Feasibility will be assessed using intervention and study completion. The number and percentage of participants assigned to IAT who complete the 12-week IAT program and the corresponding post-intervention research assessment will be calculated. Higher completion/retention rates will indicate greater feasibility.

    Measured: baseline through 12 weeks

  2. Change in attachment

    Attachment will be assessed using the self-report Personal Development School (PDS) Attachment-Style Questionnaire administered at baseline and again at the post-intervention assessment. The questionnaire characterizes participants' attachment patterns, including secure and insecure attachment styles. Change from baseline to 12 weeks will be evaluated, with movement toward greater attachment security interpreted as improvement.

    Measured: baseline and 12 weeks

Secondary outcomes (3)
  1. Change in emotion regulation, measured by the Difficulties in Emotion Regulation Scale (DERS-36)

    Emotion regulation will be assessed using the 36-item self-report Difficulties in Emotion Regulation Scale (DERS-36). Items are rated on a 5-point scale from 1 (almost never) to 5 (almost always). The total score ranges from 36 to 180. Higher scores indicate greater difficulties with emotion regulation; therefore, a decrease in score from baseline indicates improvement in emotion regulation.

    Measured: baseline and 12 weeks

  2. Change in interpersonal functioning, measured by the Inventory of Interpersonal Problems-32 (IIP-32)

    Interpersonal functioning will be assessed using the 32-item self-report Inventory of Interpersonal Problems, Short Form (IIP-32). Items are rated from 0 (not at all) to 4 (very much) and assess difficulties across eight interpersonal domains. Higher scores indicate greater interpersonal difficulties; therefore, a decrease from baseline indicates improvement in interpersonal functioning.

    Measured: baseline and 12 weeks

  3. Change in well-being, measured by the WHO-5 Well-Being Index

    Well-being will be assessed using the 5-item self-report World Health Organization 5 (WHO-5) Well-Being Index. Each item is rated from 0 to 5. Raw scores range from 0 to 25 and are multiplied by 4 to yield a score from 0 to 100. Higher scores indicate better well-being; therefore, an increase from baseline indicates improvement.

    Measured: baseline and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2026
  2. Study startDec 2026 (estimated)
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Eligible participants will be randomized 1:1 to immediate IAT or a 12-week waitlist followed by IAT.
Masking
None (open label)
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07922382
Sponsor's protocol ID
TBD not assigned
Status last verified
Oct 2026
First submitted
27 Oct 2026
Last updated
6 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing IAT in people with Attachment Disorder, run by Boston University Charles River Campus at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Meryem Yücel, PhD (617-353-1181, mayucel@bu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of IAT intervention (time frame: baseline through 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in